Cardiac Markers Rapid Tests & POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Description

List of Tables

GlobalData's Medical Devices sector report, "Cardiac Markers Rapid Tests & POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Cardiac Markers Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Markers Rapid Tests & Point of Care (POC) are rapid diagnostic tests which are simple to perform, ready to use, accurate, economic and for infield use suggested for individuals suspected with any indication.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Cardiac Markers Rapid Tests & POC under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Cardiac Markers Rapid Tests & POC and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Cardiac Markers Rapid Tests & POC under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Cardiac Markers Rapid Tests & POC Overview

3 Products under Development

3.1 Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
3.3 Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
3.4 Cardiac Markers Rapid Tests & POC - Pipeline Products by Estimated Approval Date

4 Cardiac Markers Rapid Tests & POC - Pipeline Products under Development by Companies

4.1 Cardiac Markers Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development

5 Cardiac Markers Rapid Tests & POC Companies and Product Overview

5.1 1Drop Diagnostics Company Overview
- 5.1.1 1Drop Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
5.2 Bio-AMD Inc Company Overview
- 5.2.1 Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 BiOracle Ltd (Inactive) Company Overview
- 5.3.1 BiOracle Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.4 Coris BioConcept Company Overview
- 5.4.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview
5.5 Cue Health Inc Company Overview
- 5.5.1 Cue Health Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Diazyme Laboratories Inc Company Overview
- 5.6.1 Diazyme Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Duke University Company Overview
- 5.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
5.8 Dynasil Corporation of America Company Overview
- 5.8.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview
5.9 Eachy Biopharmaceuticals Ltd Company Overview
- 5.9.1 Eachy Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.10 Maxim Biomedical Inc Company Overview
- 5.10.1 Maxim Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 MiCo BioMed Co Ltd Company Overview
- 5.11.1 MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.12 MyMD Pharmaceuticals Inc Company Overview
- 5.12.1 MyMD Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Nanomix Inc Company Overview
- 5.13.1 Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Nanospot.ai Inc Company Overview
- 5.14.1 Nanospot.ai Inc Pipeline Products & Ongoing Clinical Trials Overview
5.15 Novartis AG Company Overview
- 5.15.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
5.16 Ohmx Corp Company Overview
- 5.16.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
5.17 Thermo Fisher Scientific Inc Company Overview
- 5.17.1 Thermo Fisher Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 ThreeFold Sensors (Inactive) Company Overview
- 5.18.1 ThreeFold Sensors (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.19 True Diagnostics Inc Company Overview
- 5.19.1 True Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Upstream Medical Technologies Ltd Company Overview
- 5.20.1 Upstream Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Cardiac Markers Rapid Tests & POC- Recent Developments

6.1 Dec 18, 2023: Trinity Biotech Announces Management Changes
6.2 Oct 20, 2023: Lumiradx Partners With Astrazeneca & Everton in the Community to Set Up England's First Heart & Lung Screening Hub
6.3 Jul 06, 2023: Trinity Biotech Announces Q1 2023 Financial Results
6.4 Jun 27, 2023: bioMErieux's Executive Committee evolves: Jennifer Zinn appointed Executive Vice President of Clinical Operations
6.5 Mar 08, 2023: bioMerieux Announces 2022 Financial Results for the year ending December 31, 2022

7 Appendix

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

List of Tables

Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
Cardiac Markers Rapid

List of Figures

Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
Cardiac Markers Rapid